Sorrento Therapeutics's ticker is SRNE and the CUSIP is 83587F103.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $3,640,000 | -63.2% | 206,600 | -75.9% | 0.76% | -63.7% |
| Q1 2015 | $9,904,000 | -67.2% | 856,742 | -71.5% | 2.11% | -69.3% |
| Q4 2014 | $30,222,000 | +78.8% | 3,001,147 | -19.7% | 6.86% | +46.6% |
| Q3 2014 | $16,902,000 | -33.0% | 3,739,362 | 0.0% | 4.68% | -30.7% |
| Q2 2014 | $25,241,000 | – | 3,739,362 | – | 6.75% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|